CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 3,000 shares at an average $2.35 ($7,050)
- 4 Open-market buy Director bought 7,000 shares at an average $2.50 ($17,490)
- 4 Open-market buy Director bought 4,200 shares at $2.38 ($9,996)
- 4 Open-market buy Director bought 5,000 shares at $2.34 ($11,689)
- S-3/A Offering Registration Statement
- 4 Open-market buy Director bought 7,000 shares at an average $1.96 ($13,720)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market buy Director bought 5,000 shares at $1.59 ($7,950)
- 4 Open-market buy Director bought 7,500 shares at $1.44 ($10,825)
- 8-K Event Other events
Page 10 of 17 · 328 filings